Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 348 | 695 | -65,700 | 25,406 | 23,001 |
| Cost of Goods | 348 | 695 | -12,699 | 5,282 | 4,132 |
| Gross Profit | N/A | 0 | -53,001 | 20,124 | 18,869 |
| Operating Expenses | 15,205 | 18,570 | -78,501 | 60,327 | 54,180 |
| Operating Income | -14,857 | -17,875 | 24,801 | -39,921 | -35,179 |
| Interest Expense | 0 | 0 | 0 | 7,518 | 7,596 |
| Other Income | -16 | 0 | 25,349 | 19 | 123 |
| Pre-tax Income | -14,873 | -17,875 | 50,150 | -47,420 | -42,652 |
| Net Income Continuous | -14,873 | -17,875 | 50,150 | -47,420 | -42,652 |
| Net Income Discontinuous | 127,154 | -31,146 | N/A | N/A | N/A |
| Net Income | $112,281 | $-49,021 | $-42,960 | $-47,420 | $-42,652 |
| EPS Basic Total Ops | 12.83 | -5.70 | -4.96 | -5.62 | -5.41 |
| EPS Basic Continuous Ops | -1.70 | -2.08 | 6.74 | -5.62 | -5.41 |
| EPS Basic Discontinuous Ops | 14.53 | -3.62 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 12.83 | -5.70 | -4.96 | -5.62 | -5.41 |
| EPS Diluted Continuous Ops | -1.70 | -2.08 | 6.74 | -5.62 | -5.41 |
| EPS Diluted Discontinuous Ops | 14.53 | -3.62 | N/A | N/A | N/A |
| EBITDA(a) | $-14,575 | $-17,546 | $22,446 | $-38,891 | $-34,137 |